Quantcast

Latest Diabetes management Stories

2014-09-15 08:26:44

INDIANAPOLIS, Sept. 15, 2014 /PRNewswire/ -- Chek Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow® family of point-of-care diagnostic products, has again been named to the Inc. 5000 list of the fastest-growing private companies in America. The Inc. 5000 ranking is based on revenue growth over a three-year period. Chek Diagnostics earned its place on the list by growing its revenue by 80 percent from 2010 to 2013....

2014-09-10 23:08:06

"Five Things Women with Diabetes (WWD) Should Know about Menopause" Durham, NC (PRWEB) September 10, 2014 DiabetesSisters, the nation’s leading voice for women with diabetes, is pleased to announce that its next webinar in the Life Class Webinar Series will take place on Wednesday, September 17 at 4 PM EDT. The webinar is entitled "Five Things Women with Diabetes (WWD) Should Know about Menopause” and it's free and open to the first 100 registrants. Moderated by...

2014-09-10 16:26:29

SAN DIEGO, Sept. 10, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a stem cell-derived islet replacement therapy for the treatment of diabetes, called VC-01, announced today that it has been selected to receive a $16.6 million Accelerated Development Pathway Award from the California Institute for Regenerative Medicine (CIRM). According to CIRM, the Accelerated Development Awards were created to "provide selected applicants who are...

2014-09-09 12:29:08

Primary Research Provides Key Insights and Tools for Health Care Professionals DEERFIELD, Ill. and ALEXANDRIA, Va., Sept. 9, 2014 /PRNewswire/ -- Today, the American Diabetes Association (Association) and Takeda Pharmaceuticals, U.S.A., Inc. (Takeda) unveiled ConnecT2Day(TM), a program based on innovative research that offers new tools for health care professionals (HCPs) who are looking for additional ways to partner with patients in managing their type 2 diabetes. ConnecT2Day gathered input...

2014-09-09 08:31:17

INDIANAPOLIS, Sept. 9, 2014 /PRNewswire/ -- Fifty abstracts designed to advance knowledge in diabetes science will be presented Sept. 15-19 by Eli Lilly and Company (NYSE: LLY) at the 50(th) European Association for the Study of Diabetes (EASD) Annual Meeting. Notably, the company is highlighting two of its late-stage products: basal insulin peglispro and once-weekly dulaglutide. Twenty-eight of the abstracts will be presented as part of the Boehringer Ingelheim-Lilly Diabetes Alliance. EASD...

2014-09-08 08:26:41

Can diabetes be reversed? This medical mystery has now been solved by medical researchers with a simple 3-step diet plan MIAMI, Sept. 8, 2014 /PRNewswire/ -- Nearly 40% of American adults will develop and be diagnosed with Diabetes Type II. Diabetes is one disease from a larger group of known metabolic diseases. With Diabetes, high blood sugar levels continue over a prolonged period of time and may cause complications such as Stroke, Heart Disease, Blindness, and Kidney Failure....

2014-09-04 08:30:19

Core Phase III clinical trial program complete; BIL showed consistent HbA1c superiority against comparators INDIANAPOLIS, Sept. 4, 2014 /PRNewswire/ -- Eli Lilly and Company's (NYSE: LLY) basal insulin peglispro (BIL) demonstrated a statistically significant lower hemoglobin A1c (HbA1c) compared with insulin glargine (Lantus(®)) at 26 weeks and 52 weeks, respectively, in the IMAGINE-1 and IMAGINE-3 Phase III clinical trials in patients with type 1 diabetes. Patients in these...

2014-09-04 08:29:52

Mithril Capital Management Leads $40M Series C Financing to Join Early Investors General Catalyst, Bessemer and Domain Associates WALTHAM, Mass., Sept. 4, 2014 /PRNewswire/ -- Fractyl Laboratories Inc. today announced positive clinical data for the first procedural therapy to directly treat the underlying digestive causes of insulin resistance in patients with uncontrolled type 2 diabetes. The non-invasive Revita(TM) Duodenal Mucosal Resurfacing(TM) (DMR) procedure is designed to...

breakfast
2014-09-03 02:45:10

Maya Sandler, PLOS Regular consumption of a healthy breakfast may help children lower their risk of developing type 2 diabetes, according to a study published in this week's PLOS Medicine. The study, conducted by Angela Donin of St. George's University of London and colleagues, found an association between children who reported skipping breakfast most days and higher levels of known diabetes risk factors. The researchers reached these conclusions after conducting a cross-sectional study...

2014-09-03 08:35:26

- FreeStyle Libre System eliminates routine finger pricks for glucose measurements1 and requires no finger pricks for calibration ABBOTT PARK, Ill., Sept. 3, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has received CE Mark (Conformite Europeenne) for its FreeStyle(®) Libre Flash Glucose Monitoring System, a revolutionary new glucose sensing technology for people with diabetes. The system eliminates the need for routine finger pricks(1), reading glucose levels through a...


Latest Diabetes management Reference Libraries

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (1 articles) »
Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.